Internal biokinetic behaviour of molybdenum in humans studied with stable isotopes as tracers

被引:12
作者
Werner, E
Roth, P
Heinrichs, U
Giussani, A
Cantone, MC
Zilker, T
Felgenhauer, N
Greim, H
机构
[1] GSF, Natl Res Ctr Environm & Hlth, Inst Radiat Protect, Oberschleissheim, Germany
[2] Univ Milan, Dept Phys, Milan, Italy
[3] Tech Univ Munich, Dept Toxicol, Med Clin 2, D-8000 Munich, Germany
[4] GSF, Natl Res Ctr Environm & Hlth, Inst Toxikol, Oberschleissheim, Germany
关键词
biokinetics; molybdenum; 95/96; molybdenum metabolism; tracer kinetics; human;
D O I
10.1080/10256010008032938
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Although molybdenum is considered to be an essential trace metal for humans, the knowledge about its metabolism is rather limited. The present study was aimed at the assessment of biokinetics following intravenous injection of trace amounts of Mo-95 or Mo-96 into Eve healthy volunteers. In a total of 11 investigations, the plasma clearance up to eight hours and the urinary excretion for at least three days after the injection were evaluated. The tracer concentrations were determined by proton nuclear activation analysis in blood plasma and by thermal ionization mass spectrometry in urine samples respectively. In all subjects, the plasma clearance is much faster than expected from the literature. The data obtained for the plasma clearance of the tracer can reasonably be fitted by a two exponential equation. The half times of the fast component range between 4 and 70 minutes and for the slow component between 3 and 30 hours. The urinary excretion of the injected tracer seems also to be faster than expected and the fractions lost are higher for larger doses administered. For the smallest dose given, 34% of the injected tracer were excreted within one day whereas for the four times larger dose about 60% were lost. These findings on urinary excretion are in agreement with recently published results.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 19 条
[1]   AMINO-ACID INTOLERANCE DURING PROLONGED TOTAL PARENTERAL-NUTRITION REVERSED BY MOLYBDATE THERAPY [J].
ABUMRAD, NN ;
SCHNEIDER, AJ ;
STEEL, D ;
ROGERS, LS .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (11) :2551-2559
[2]  
ABUMRAD NN, 1984, B NEW YORK ACAD MED, V60, P163
[3]  
AMY NK, 1988, TRACE ELEMENTS MAN A, V6, P301
[4]  
[Anonymous], 1963, BODY COMPOSITION HLT
[5]   MOLYBDENUM COFACTOR DEFICIENCY [J].
ARNOLD, GL ;
GREENE, CL ;
STOUT, JP ;
GOODMAN, SI .
JOURNAL OF PEDIATRICS, 1993, 123 (04) :595-598
[6]   SHORT-TERM RESPONSE TO DIETARY THERAPY IN MOLYBDENUM COFACTOR DEFICIENCY [J].
BOLES, RG ;
MENT, LR ;
MEYN, MS ;
HORWICH, AL ;
KRATZ, LE ;
RINALDO, P .
ANNALS OF NEUROLOGY, 1993, 34 (05) :742-744
[7]   PROTON ACTIVATION-ANALYSIS OF STABLE ISOTOPES FOR A MOLYBDENUM BIOKINETICS STUDY IN HUMANS [J].
CANTONE, MC ;
DEBARTOLO, D ;
GAMBARINI, G ;
GIUSSANI, A ;
OTTOLENGHI, A ;
PIROLA, L ;
HANSEN, C ;
ROTH, P ;
WERNER, E .
MEDICAL PHYSICS, 1995, 22 (08) :1293-1298
[8]   A methodology for biokinetic studies using stable isotopes: Results of repeated molybdenum investigations on a healthy volunteer [J].
Cantone, MC ;
DeBartolo, D ;
Giussani, A ;
Ottolenghi, A ;
Pirola, L ;
Hansen, C ;
Roth, P ;
Werner, E .
APPLIED RADIATION AND ISOTOPES, 1997, 48 (03) :333-338
[9]  
COHEN HJ, 1971, J BIOL CHEM, V246, P374
[10]   Thermal ionization and inductively coupled plasma mass spectrometry: Potential for application to studies on the biokinetics of molybdenum in humans [J].
Giussani, A ;
Roth, P ;
Werner, E ;
Schramel, P ;
Wendler, I ;
Nusslin, F .
ISOTOPES IN ENVIRONMENTAL AND HEALTH STUDIES, 1998, 34 (1-2) :207-215